These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7010171)

  • 1. DES versus tamoxifen in advanced breast cancer.
    N Engl J Med; 1981 Apr; 304(17):1041-3. PubMed ID: 7010171
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial.
    Gockerman JP; Spremulli EN; Raney M; Logan T
    Cancer Treat Rep; 1986 Oct; 70(10):1199-203. PubMed ID: 3530447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.
    Mouridsen HT; Salimtschik M; Dombernowsky P; Gelshoj K; Palshof T; Rorth M; Daehnfeldt JL; Rose C
    Eur J Cancer (1965); 1980; Suppl 1():107-10. PubMed ID: 7032918
    [No Abstract]   [Full Text] [Related]  

  • 4. Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer.
    Beex L; Pieters G; Smals A; Koenders A; Benraad T; Kloppenborg P
    Cancer Treat Rep; 1981; 65(3-4):179-85. PubMed ID: 7237448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.
    Stewart HJ; Forrest AP; Gunn JM; Hamilton T; Langlands AO; McFadyen IJ; Roberts MM
    Eur J Cancer (1965); 1980; Suppl 1():83-8. PubMed ID: 7032945
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prospective randomized study of the efficacy of adjuvant hormone therapy in patients with breast cancer].
    Semiglazov VF; Moiseenko VM; Ivanova OA
    Vopr Onkol; 1986; 32(8):31-4. PubMed ID: 3532535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary report of a controlled trial in advanced breast cancer comparing tamoxifen with conventional hormone therapy.
    Roberts HM; Forrest AP; Hamilton T; Langlands AO; Lutz W; McFadyen IJ; Stewart HJ
    Cancer Treat Rep; 1976 Oct; 60(10):1461-2. PubMed ID: 798627
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant endocrine therapy of primary operable breast cancer. Report on the Copenhagen breast cancer trials.
    Palshof T; Mouridsen HT; Daehnfeldt JL
    Eur J Cancer (1965); 1980; Suppl 1():183-7. PubMed ID: 7032931
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer.
    McFadyen IJ; Raab G; Forrest AP; Langlands AO; Stewart HJ; Roberts MM; Hamilton T; Golder MP; Groom GV; Griffiths K
    Clin Oncol; 1979 Sep; 5(3):251-6. PubMed ID: 387323
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical control of metastases in patients with advanced cancer of the breast.
    Sellwood RA; Burn I; Fotherby K
    Proc R Soc Med; 1974 Sep; 67(9):854-7. PubMed ID: 4610590
    [No Abstract]   [Full Text] [Related]  

  • 11. Tamoxifen in the palliative treatment of advanced breast cancer. A clinical review.
    Orr JD; Macdonald JA; Thomson JW
    J R Coll Surg Edinb; 1979 May; 24(3):141-7. PubMed ID: 88517
    [No Abstract]   [Full Text] [Related]  

  • 12. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the treatment of advanced breast cancer with tamoxifen].
    Wieckowska Z
    Pol Tyg Lek; 1985 Aug; 40(34):967-71. PubMed ID: 3906599
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity].
    Murayama Y
    Gan No Rinsho; 1984 Dec; 30(15):1879-82. PubMed ID: 6543230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormonal treatment of breast cancer in men. Experiences with antiestrogen Tamoxifen].
    Telhaug R; Fosså SD; Lund G; Børmer O
    Tidsskr Nor Laegeforen; 1982 Dec; 102(34-36):1849-51. PubMed ID: 7170693
    [No Abstract]   [Full Text] [Related]  

  • 16. Symposium on the management of early breast cancer (stages I and II). Part II: Clinical experience with treatment methods. 5. Adjuvant endocrine therapy.
    Palshof T
    Can J Surg; 1981 Jul; 24(4):379-84. PubMed ID: 7023634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of sex hormones on peripheral immunity in patients with advanced breast cancer.
    Franks CR; Williams Y
    Clin Oncol; 1978 Mar; 4(1):19-24. PubMed ID: 639376
    [No Abstract]   [Full Text] [Related]  

  • 18. Tamoxifen and breast cancer--from palliation to prevention.
    Rich SE
    Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended tamoxifen therapy for advanced breast cancer. Clinical experience at Siriraj Hospital.
    Tepmongkol P; Suphaphongs N; Chantarakul N; Thansakul A
    J Med Assoc Thai; 1986 Dec; 69(12):635-40. PubMed ID: 3572276
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethinylestradiol and diethylstilbestrol induced antibodies and vascular thrombosis.
    Beaumont V; Lemort N; Abbou CC; Beaumont JL
    Biomedicine; 1980 Feb; 32(1):26-31. PubMed ID: 7370379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.